Is staging mediastinoscopy necessary before stereotactic body radiotherapy for inoperable early stage lung cancer?

about

Is staging mediastinoscopy necessary before stereotactic body radiotherapy for inoperable early stage lung cancer?

Item

http://www.wikidata.org/entity/Q42108214

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@en

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@nl

type

Item

label

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@en

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@nl

prefLabel

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@en

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@nl

P1476

Is staging mediastinoscopy nec ...... rable early stage lung cancer?

@en

P2093

Jean-Claude M Rwigema

http://www.w3.org/2001/XMLSchema#string

Percy Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

Systemic effects of local radiotherapy.

Optimization of mediastinal staging in potential candidates for stereotactic radiosurgery of the chest.

Stereotactic body radiotherapy for stage I non-small cell lung cancer.

Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.

Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.

Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.

P304

E612-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.2072-1439.2015.12.54

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26793372

http://www.w3.org/2001/XMLSchema#string

P932

4703637

http://www.w3.org/2001/XMLSchema#string